EUVIMEDEUVIMED entdecken
ValidierungsstudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis

Kyoko Saito, Avinash Gabbeta, Evan Mulvihill, Lina Al-Jaberi, Timothy Beukelman, James D Lewis, Carlos D Rose, Brian L Strom, Daniel B Horton iD

Pharmacoepidemiology and Drug Safety · 2024

DOI: 10.1002/pds.5803 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Kyoko Saito und 8 weiteren Autor:innen. Beteiligte Einrichtung: Brown University, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Arthritis, Juvenile, Algorithms, Antirheumatic Agents, Electronic Health Records. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To facilitate claims‐based research on populations with juvenile idiopathic arthritis (JIA), we sought to validate an algorithm of new medication use as a proxy for worsening JIA disease activity.

Methods

Using electronic health record data from three pediatric centers, we defined new JIA medication use as (re)initiation of disease‐modifying antirheumatic drugs or glucocorticoids (oral or intra‐articular). Data were collected from 201 randomly selected subjects with (101) or without (100) new medication use. We assessed the positive predictive value (PPV) and negative predictive value (NPV) based on a reference standard of documented worsening of JIA disease activity. The algorithm was refined to optimize test characteristics.

Results

Overall, the medication‐based algorithm had suboptimal performance in representing worsening JIA disease activity (PPV 69.3%, NPV 77.1%). However, algorithm performance improved for definitions specifying longer times after JIA diagnosis (≥1‐year post‐diagnosis: PPV 82.9%, NPV 80.0%) or after initiation of prior JIA treatment (≥1‐year post‐treatment: PPV 89.7%, NPV 80.0%).

Conclusion

An algorithm for new JIA medication use appears to be a reasonable proxy for worsening JIA disease activity, particularly when specifying new use ≥1 year since initiating a prior JIA medication. This algorithm will be valuable for conducting research on JIA populations within administrative claims databases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, JuvenileAlgorithmsAntirheumatic AgentsElectronic Health RecordsGlucocorticoidsHumansChildFemaleMaleAdolescentChild, PreschoolDisease ProgressionPredictive Value of Tests

Stichwörter der Autor:innen

algorithmsjuvenile arthritispharmacoepidemiologyroutinely collected health datavalidation study

Substanzen

Antirheumatic AgentsGlucocorticoids

Autor:innen und Institutionen

  • Brown University, Providence, Rhode Island, USA.
  • St. Christopher's Hospital for Children, Philadelphia, Pennsylvania, USA.
  • Nemours Children's Hospital, Wilmington, Delaware, USA.
  • Arkansas Children's Hospital, Little Rock, Arkansas, USA.
  • Childhood Arthritis & Rheumatology Research Alliance, Washington, DC, USA.
  • Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Daniel B Horton

Förderung

  • NCATS NIH HHS
  • NIAMS NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Center for Advancing Translational Sciences

Zitieren

APA

Saito, K., Gabbeta, A., Mulvihill, E., Al-Jaberi, L., Beukelman, T., Lewis, J. D., Rose, C. D., Strom, B. L., & Horton, D. B. (2024). Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5803

Vancouver

Saito K, Gabbeta A, Mulvihill E, Al-Jaberi L, Beukelman T, Lewis JD, et al. Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.5803

BibTeX
@article{Saito2024,
  author = {Saito, Kyoko and Gabbeta, Avinash and Mulvihill, Evan and Al-Jaberi, Lina and Beukelman, Timothy and Lewis, James D and Rose, Carlos D and Strom, Brian L and Horton, Daniel B},
  title = {Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2024},
  doi = {10.1002/pds.5803}
}
Kostenlos starten →